Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.

Christelle Ferra Coll,Mireia Morgades de la Fe,Laura Prieto García,Carlos Pinho Vaz,María Inmaculada Heras Fernando,Rebeca Bailen Almorox,Irene Garcia-Cadenas,Marisa Calabuig Muñoz,Teresa Zudaire Ripa,Joud Zanabili Al-Sibai, Sandra Novoa,Beatriz Aguado,Anna Torrent Catarineu,Oriana López-Godino,Rodrigo Martino Bofarull,Mi Kwon,Antonio Campos Júnior,Dolores Caballero Barrigón,Josep-Maria Ribera Santasusana

European journal of haematology（2023）

引用 0|浏览29

暂无评分

摘要

Despite the poor prognosis of patients with ALL presenting relapse after a first allo-SCT, some can be satisfactorily rescued and a second allo-SCT still remains a valid option for selected patients. Moreover, emerging therapies really might improve ALL patients outcome when relapsing after an allo-SCT.

查看译文

关键词

acute lymphoblastic leukaemia,allogeneic haematopoietic stem cell transplant,relapse

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要